Latest debt-to-equity ratio
CytomX Therapeutics Debt-to-equity ratio
Direct answer
CytomX Therapeutics's debt-to-equity ratio is 1.89%.
The verified market snapshot reports 1.89%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 7, 2026.
Get free CytomX Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 1.89%
Explore related company data
View CytomX Therapeutics's market capitalizationView CytomX Therapeutics's price-to-book ratioView CytomX Therapeutics's return on equityView CytomX Therapeutics's dividend yieldView CytomX Therapeutics's 52-week price rangeView CytomX Therapeutics's revenue growthView CytomX Therapeutics's profit marginView all CytomX Therapeutics key metricsReturn to CytomX Therapeutics profile